Clinical Trial Update: Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating growth response to somatropin in children with idiopathic short stature.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Idiopathic Short Stature | Phase 2 | Status: COMPLETED